CAR T-cell immunotherapy may become the alternative option to current life-long retroviral therapy for HIV patients By BRANDON NGUYEN — science@theaggie.org   According to the Joint United Nations Programme on AIDS/HIV or UNAIDS, around 38 million people worldwide live with HIV, a retrovirus that destroys a host’s own immune cells and can progress into AIDS … Continue reading CAR T-cell therapy currently in UC Davis Health clinical trial study as potential cure for HIV